MEDINET Co. Amends TC BioPharm Stake Filing

TL;DR

**MEDINET Co. is still holding its stake in TC BioPharm.**

AI Summary

MEDINET Co., Ltd. filed an amended SC 13G/A on January 29, 2024, indicating their beneficial ownership in TC BioPharm (Holdings) plc as of December 31, 2023. This filing, an amendment to a previous statement, confirms MEDINET's continued passive investment in the biological products company. This matters to investors because it shows a significant institutional holder maintaining their position, which can be interpreted as a vote of confidence in TC BioPharm's long-term prospects.

Why It Matters

This filing confirms a major institutional investor, MEDINET Co., Ltd., is maintaining its position in TC BioPharm, signaling continued confidence in the company's future.

Risk Assessment

Risk Level: low — This filing is a routine update on beneficial ownership and does not indicate any immediate new risks or significant changes.

Analyst Insight

Investors should note that MEDINET Co., Ltd. is maintaining its passive stake in TC BioPharm, suggesting no immediate change in their investment thesis. This could be a positive signal for long-term holders, but further research into TC BioPharm's fundamentals and MEDINET's overall strategy would be prudent.

Key Players & Entities

• MEDINET Co., Ltd. (company) — the reporting person and beneficial owner
• TC BioPharm (Holdings) plc (company) — the subject company whose securities are being reported
• December 31, 2023 (date) — the date of the event requiring the filing
• January 29, 2024 (date) — the filing date of the SC 13G/A amendment

FAQ

Filing Documents

• medinet_sc13ga.htm (SC 13G/A) — 60KB
• 0000929638-24-000212.txt ( ) — 61KB

(a) for each such Reporting Person

Item 4(a) for each such Reporting Person. (b) Percent of Class The information set forth in Rows 5 through 11 on the cover page for each Reporting Person is hereby incorporated by reference into this

(b) for each such Reporting Person

Item 4(b) for each such Reporting Person. (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote (ii) shared power to vote or to direct the vote (iii) Sole power to dispose or to direct the disposition of (iv) shared power to dispose or to direct the disposition of The information set forth in Rows 5 through 11 on the cover page for each Reporting Person is hereby incorporated by reference into this Item 4(c) for each such Reporting Person. Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X]. Item 6. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not applicable. Item 8. Identification and Classification of Members of the Group Not applicable. Item 9. Notice of Dissolution of Group Not applicable. Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: January 29, 2024 MEDINET Co., Ltd By: /s/ Masami Ochiai Name: Masami Ochiai Title: General Manager, Corporate Management Dept.

View Full Filing

View this SC 13G/A filing on SEC EDGAR